期刊文献+

恶性颈动脉体瘤1例报告及文献复习 被引量:3

Malignant carotid body tumor: Report of one case and literature review
下载PDF
导出
摘要 恶性颈动脉体瘤临床罕见,迄今国内外文献报道病例仅100余例。其特征是肿瘤侵犯包膜及周围组织,颈部淋巴结和(或)远处转移,组织学表现为异型性。我科1993~2004年间收治颈动脉体瘤患者28例,恶性仅1例,且为术后5年复发患者。该例恶性颈动脉体瘤患者伴同侧颈淋巴结转移,行肿瘤扩大切除及受累颈动脉切除,颈动脉人工血管重建,术后无脑神经并发症发生。随访6个月,未见肿瘤复发。 Malignant carotid body tumor(CBT) is a rarely seen and controversial neoplasm. It is characterized by extracapsular invasion, metastasis to the cervical lymph nodes or distant organs and histopathological atypia. From 1993 to 2004, 28 patients with CBT were diagnosed and surgically treated in our department; only one malignant (also recurrent 5 years after the first operation) case was found. This paper reported this unusual patient with recurrent malignant carotid body tumor as well as cervical lymph nodes metastases. Carotid artery reconstruction was performed with artificial vascular graft after ablative resection of the tumor and involved artery. No stroke, early or late complications occurred and no relapse was detected during the follow up of 6 months. Early surgical intervention is proposed to improve the patient's survive rate and quality of life. Supported by Research Fund of the Ministry of Public Health (Grant No.96-1-340) and Sustentation Plan for Excellent Academic Leader of Shanghai Municipality (Grant No.96XD14013).
出处 《中国口腔颌面外科杂志》 CAS 2005年第2期171-174,共4页 China Journal of Oral and Maxillofacial Surgery
基金 卫生部科研基金(96-1-340) 上海市优秀学科带头人资助计划(96XD14103)
关键词 颈动脉体瘤 恶性颈动脉体瘤 化学感受器瘤 副神经节瘤 Carotid body tumor Malignant carotid body tumor Chemodectoma Paraganglioma
  • 相关文献

参考文献11

  • 1[1]Lazaro B, Klemz M, Flores MS, et al. Malignant paraganglioma with vertebral metastasis: case report [J]. Arq Neuro-Psiquiatr,2003,61 (2B):463 -467.
  • 2[2]Mall J, Saclarides T, Doolas A, et al. First report of hepatic lobectomy for metastatic carotid body tumor[J]. J Cardiovasc Surg (Torino), 2000,41(5):759-761.
  • 3[3]Pacheco-Ojeda L. Malignant carotid body tumors: report of three cases[J]. Ann Otol Rhinol Laryngol, 2001,110(1):36-40.
  • 4[4]Kumaki N, Kajiwara H, Kameyama K, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques[J]. Endocr Pathol, 2002,13(2):149-156.
  • 5[5]Barnes L, Talor SR. Carotid body paragangliomas. A clinicopathologic and DNA analysis of 13 tumors [J]. Arch Otolaryngol Head Neck Surg, 1990, 116(4):447-453.
  • 6[6]Lee JH, Barich F, Karnell LH, et al. National cancer data base report on malignant paragangliomas of the head and neck. Cancer,2002,94:730-737.
  • 7陶英杰,刘经祖,金锐.10例恶性颈动脉体瘤之生物学行为分析[J].中国肿瘤临床,2001,28(4):288-289. 被引量:5
  • 8[8]Somasundar P, Krouse R, Hostetter R, et al. Paragangliomas-- a decade of clinical experience [J]. J Surg Oncol, 2000,74(4):286-290.
  • 9[9]Patetsios P, Gable DR, Garrett WV, et al. Management of carotid body paragangliomas and review of a 30-year experience [J]. Ann Vasc Surg. 2002,16(3):331-338.
  • 10[10]Mayer R, Fruhwirth J, Beham A, et al. Radiotherapy as adjunct to surgery for malignant carotid body paragangliomas presenting with lymph node metastases[J]. Strahlenther Onkol, 2000,176(8): 356-360.

二级参考文献2

共引文献4

同被引文献42

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部